Ignite Creation Date:
2024-05-06 @ 7:43 PM
Last Modification Date:
2024-10-26 @ 3:12 PM
Study NCT ID:
NCT06110182
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-10-31
First Post:
2023-10-26
Brief Title:
Evaluation of the Advantage in the Use of Enteral Nutrition in Children Treated for Acute Lymphoblastic Leukemia
Sponsor:
Central Hospital Nancy France
Organization:
Central Hospital Nancy France
Study Overview
Official Title:
Evaluation of the Advantage in the Use of Enteral Nutrition in Children Treated for Acute Lymphoblastic Leukemia
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2023-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a multicenter retrospective study Reims and Nancy with data collection over 12 years from 01012010 to 12312022 Patients included are children diagnosed with acute lymphoblastic leukemia between 2010 and 2021 in the 2 centers
Patients will be categorized into 3 groups
No nutritional support
Support by enteral nutrition
Parenteral nutrition support Their nutritional status will be assessed at the end of induction at 6 months and then at 12 months from diagnosis
The main objective of this study is therefore to compare the nutritional status of children with acute lymphoblastic leukemia depending on whether they received enteral or parenteral nutritional support during their treatment
The secondary objective is to evaluate the occurrence of complications during treatment according to the nutritional support received
Patients will be categorized into 3 groups
No nutritional support
Support by enteral nutrition
Parenteral nutrition support Their nutritional status will be assessed at the end of induction at 6 months and then at 12 months from diagnosis
The main objective of this study is therefore to compare the nutritional status of children with acute lymphoblastic leukemia depending on whether they received enteral or parenteral nutritional support during their treatment
The secondary objective is to evaluate the occurrence of complications during treatment according to the nutritional support received
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None